Hubungan Antara Red Blood Cell Count (Rbc) Dan Retinopati Diabetik Pada Pasien Diabetes Melitus Tipe 2
DAFTAR PUSTAKA
1. PERKENI 2011. Konsensus Pengelolaan dan pencegahan Diabetes Mellitus tipe 2
tipe 2 di Indonesia. Jakarta.PB PERKENI.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of Diabetes ;
estimates for the year 2000 and projection for 2030. Diabetes Care 2004. 27(5);
1047-53.
3. Wang ZS, Song ZC, Bai JH, Li Fei, et al. Red Blood Cell Count As An Indicator of
Microvascular Complications in Chinese Patients With Type 2 Diabetes Mellitus
tipe 2. Vascular Health and Risk Management. 2013;9; 237-43.
4. Gunderson CA, Karnath B.‘Retinal Manifestation of Diabetes and Hypertension’,
Hospital Physician. 2003.pp.15-18.
5. Irace C, Scarinci F, Scorcia V, Bruzzichessi D, et al. Association between low
Whole Blood Viscosity, Hematocrit, Hemoglobin and Diabetic Retinopathy in
subjects with type 2 diabetes. British Journal of Opthalmology. 2010.
6. Budak Y, Demirci H, Akdogan M, Yavuz D. Erytrocyte membrane anionic charge
in type 2 diabetic patients with retinopathy. BMC Opthamology. 2004.4;14.p1-6.
7. Sutedjo AY,‘Mengenal Penyakit Melalui Pemeriksaan Laboratorium’, Penerbit
Amara Books.
8. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the
Diagnosis of Diabetes Mellitus tipe 2 Abbreviated Report of a WHO
Consultation. World Health Organization. 2011.
9. Cho YI, Mooney MP, Cho DJ. Hemorrheological Disorders in Diabetes Mellitus
tipe 2. Journal of Diabetes Science and Technology. 2008;2:1130-38.
10. Wanda Lockwood. The complete Blood Test and Associated Test.2013. diunduh
dari www.rn.org/courses/coursematerial-263.pdf. diakses tanggal 24 Maret
2014.
11. Jabeen F, Rizvi HA, Azis F, Wasti AZ. Hyperglycemic induced variations in
Hematological Indices in Type 2 Diabetics. International Journal of Advanced
Research. 2013;1: 322-34.
12. Mazzanti L, Faloia E, Rabini RA, et al. Diabetes Mellitus tipe 2 induces red blood
cell plasma membrane alterations possibly affecting the aging process. Clin
Biochem. 1992;25(1):41– 6.
13. Cohen RM, Franco RS, Khera PK, Smith EP,et al. Red cell life span heterogeneity
in hematologically normal people is sufficient to alter HbA1c. BLOOD Journal.
2008; 112: 4284-91.
14. Huang YX, Wu ZJ, Mehrishi J, Huang BT, Chen XY, Zheng XJ et al. Human Red
Blood Cell Aging : correlative changes in surface charge and cell properties.
J.Cell. Mol. Med. 2011;15:2634-42.
15. Jindal S, Gupta S, Gupta R et al. Platelet indices in Diabetes Mellitus tipe 2:
indicators of diabetic microvascular complications.Hematology. 2011;16:86-9.
16. Yngen M. Platelet function in Diabetes Mellitus tipe 2. International Journal of
Endocrinology. 2005.
17. Da Silva SB, Costa JP, Pintado ME, Ferreira DC, Sarmento B. Antioxidants in the
Prevention and treatment of Diabetic Retinopathy- A Review. 2009
18. Shotliff K, Duncan G. Diabetic Retinopathy: summary of grading and
management. Pract Diab Int. 2006;23:418-20.
19. Bondello F, Menchini F. New Insight into the Pathogenesis of Diabetic
Retinopathy. John Hopkins Advanced Studies In Opthalmology. 2008;5:16-21.
20. Lang GK et al. Diabetic retinopathy in: Opthalmology A Short Textbook. Times
New York. 2000 ; 314-18.
21. Vislisel
J,
Oetting
T.
Diabetic
Retinopathy.
2010.
Diunduh
dari
www.EyeRounds.org. diakses tanggal 29 januari 2014.
22. Rohilla A, Kumar R, Rohilla S, Kushnoor A. Diabetic Retinopathy: Origin and
Complications. European Journal of Experimental Biology.2012; 2 (1):88-94.
23. American Academy Of Opthalmology. Diabetic Retinopathy. American Academy
of Opthalmology. 2008.
24. Fong DS, Aiello LP, Ferris FL, Klein R et al. Diabetic Retinopathy. Diabetes Care.
2004; 27: 2540-53.
25. Gartner, Hiatt. Hematopoietic system I Peripheral Blood. Diunduh dari
http/www.uth.tmc.edupathologymedicimmunologyImmunoBloodandHematopo
iesis.pdf.pdf . diakses pada tanggal 24 Maret 2014.
26. Lim TW. The effect of red blood cell aggregation and how it can be reversed.
2010. Diunduh dari www.mediclights.com/wp-content/uploads/2011/09/RBCaggregation-research1.pdf. diakses pada tanggal 24 Maret 2014.
27. Singh DK et al. Advances in the diagnosis and management of hyperinsulinemic
hypoglycemia Nat Rev Endocrinol. 2009. 204-10
28. Brown CD, Ghali HS, Zhao Z, Thomas LL, et al. Association of reduced red blood
cell deformability and diabetic nephropathy. Kidney International. 2005; 67:
295–300
29. Kostova V, Antonovaa N, Velchevab I, Ivanova I. Comparative analysis of the
rheological properties of blood in patients with type 2 diabetes V. Series on
Biomechanics. 2012; 27: 80-5.
30. Hussain S, Qamar MR, Iqbal MA, Ahmad A, Ullah E. Risk factors of retinopathy in
type 2diabetes mellitus at a tertiary care hospital, Bahawalpur Pakistan. Pak J
Med Sci. 2013;2;p 536-9.
31. Chatziralli IP, sergentanis TN, Keyttopaulos P, Vatkalis N,et al. Risk factors
associated with diabetic retinopathy in patients with diabetes mellitus type 2.
Biomed Central. 2010;3:153.
32. Zhong ZL, Han M, Chen S. Risk factors associated with retinal neovascularization
of diabetic retinopathy in type 2 diabetes mellitus. Int. J.Opthalmol. 2011:182-5.
1. PERKENI 2011. Konsensus Pengelolaan dan pencegahan Diabetes Mellitus tipe 2
tipe 2 di Indonesia. Jakarta.PB PERKENI.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of Diabetes ;
estimates for the year 2000 and projection for 2030. Diabetes Care 2004. 27(5);
1047-53.
3. Wang ZS, Song ZC, Bai JH, Li Fei, et al. Red Blood Cell Count As An Indicator of
Microvascular Complications in Chinese Patients With Type 2 Diabetes Mellitus
tipe 2. Vascular Health and Risk Management. 2013;9; 237-43.
4. Gunderson CA, Karnath B.‘Retinal Manifestation of Diabetes and Hypertension’,
Hospital Physician. 2003.pp.15-18.
5. Irace C, Scarinci F, Scorcia V, Bruzzichessi D, et al. Association between low
Whole Blood Viscosity, Hematocrit, Hemoglobin and Diabetic Retinopathy in
subjects with type 2 diabetes. British Journal of Opthalmology. 2010.
6. Budak Y, Demirci H, Akdogan M, Yavuz D. Erytrocyte membrane anionic charge
in type 2 diabetic patients with retinopathy. BMC Opthamology. 2004.4;14.p1-6.
7. Sutedjo AY,‘Mengenal Penyakit Melalui Pemeriksaan Laboratorium’, Penerbit
Amara Books.
8. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the
Diagnosis of Diabetes Mellitus tipe 2 Abbreviated Report of a WHO
Consultation. World Health Organization. 2011.
9. Cho YI, Mooney MP, Cho DJ. Hemorrheological Disorders in Diabetes Mellitus
tipe 2. Journal of Diabetes Science and Technology. 2008;2:1130-38.
10. Wanda Lockwood. The complete Blood Test and Associated Test.2013. diunduh
dari www.rn.org/courses/coursematerial-263.pdf. diakses tanggal 24 Maret
2014.
11. Jabeen F, Rizvi HA, Azis F, Wasti AZ. Hyperglycemic induced variations in
Hematological Indices in Type 2 Diabetics. International Journal of Advanced
Research. 2013;1: 322-34.
12. Mazzanti L, Faloia E, Rabini RA, et al. Diabetes Mellitus tipe 2 induces red blood
cell plasma membrane alterations possibly affecting the aging process. Clin
Biochem. 1992;25(1):41– 6.
13. Cohen RM, Franco RS, Khera PK, Smith EP,et al. Red cell life span heterogeneity
in hematologically normal people is sufficient to alter HbA1c. BLOOD Journal.
2008; 112: 4284-91.
14. Huang YX, Wu ZJ, Mehrishi J, Huang BT, Chen XY, Zheng XJ et al. Human Red
Blood Cell Aging : correlative changes in surface charge and cell properties.
J.Cell. Mol. Med. 2011;15:2634-42.
15. Jindal S, Gupta S, Gupta R et al. Platelet indices in Diabetes Mellitus tipe 2:
indicators of diabetic microvascular complications.Hematology. 2011;16:86-9.
16. Yngen M. Platelet function in Diabetes Mellitus tipe 2. International Journal of
Endocrinology. 2005.
17. Da Silva SB, Costa JP, Pintado ME, Ferreira DC, Sarmento B. Antioxidants in the
Prevention and treatment of Diabetic Retinopathy- A Review. 2009
18. Shotliff K, Duncan G. Diabetic Retinopathy: summary of grading and
management. Pract Diab Int. 2006;23:418-20.
19. Bondello F, Menchini F. New Insight into the Pathogenesis of Diabetic
Retinopathy. John Hopkins Advanced Studies In Opthalmology. 2008;5:16-21.
20. Lang GK et al. Diabetic retinopathy in: Opthalmology A Short Textbook. Times
New York. 2000 ; 314-18.
21. Vislisel
J,
Oetting
T.
Diabetic
Retinopathy.
2010.
Diunduh
dari
www.EyeRounds.org. diakses tanggal 29 januari 2014.
22. Rohilla A, Kumar R, Rohilla S, Kushnoor A. Diabetic Retinopathy: Origin and
Complications. European Journal of Experimental Biology.2012; 2 (1):88-94.
23. American Academy Of Opthalmology. Diabetic Retinopathy. American Academy
of Opthalmology. 2008.
24. Fong DS, Aiello LP, Ferris FL, Klein R et al. Diabetic Retinopathy. Diabetes Care.
2004; 27: 2540-53.
25. Gartner, Hiatt. Hematopoietic system I Peripheral Blood. Diunduh dari
http/www.uth.tmc.edupathologymedicimmunologyImmunoBloodandHematopo
iesis.pdf.pdf . diakses pada tanggal 24 Maret 2014.
26. Lim TW. The effect of red blood cell aggregation and how it can be reversed.
2010. Diunduh dari www.mediclights.com/wp-content/uploads/2011/09/RBCaggregation-research1.pdf. diakses pada tanggal 24 Maret 2014.
27. Singh DK et al. Advances in the diagnosis and management of hyperinsulinemic
hypoglycemia Nat Rev Endocrinol. 2009. 204-10
28. Brown CD, Ghali HS, Zhao Z, Thomas LL, et al. Association of reduced red blood
cell deformability and diabetic nephropathy. Kidney International. 2005; 67:
295–300
29. Kostova V, Antonovaa N, Velchevab I, Ivanova I. Comparative analysis of the
rheological properties of blood in patients with type 2 diabetes V. Series on
Biomechanics. 2012; 27: 80-5.
30. Hussain S, Qamar MR, Iqbal MA, Ahmad A, Ullah E. Risk factors of retinopathy in
type 2diabetes mellitus at a tertiary care hospital, Bahawalpur Pakistan. Pak J
Med Sci. 2013;2;p 536-9.
31. Chatziralli IP, sergentanis TN, Keyttopaulos P, Vatkalis N,et al. Risk factors
associated with diabetic retinopathy in patients with diabetes mellitus type 2.
Biomed Central. 2010;3:153.
32. Zhong ZL, Han M, Chen S. Risk factors associated with retinal neovascularization
of diabetic retinopathy in type 2 diabetes mellitus. Int. J.Opthalmol. 2011:182-5.